Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.
June 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 |
July 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 | 31 |
August 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | ||||
4 | 5 | 6 | 7 | 8 | 9 | 10 |
11 | 12 | 13 | 14 | 15 | 16 | 17 |
18 | 19 | 20 | 21 | 22 | 23 | 24 |
25 | 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on July 15, 2025

Green Steel Industry Growing Fast with 21.4% CAGR
Boston, July 15, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Global Green Steel Market" is expected to grow from $7.4 billion in 2024 to $19.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.4% from …

Aegle Therapeutics Names Industry Veteran Scott Braunstein, M.D. as Chairman of the Board
BOSTON, July 15, 2025 (GLOBE NEWSWIRE) -- Aegle Therapeutics, a clinical-stage dermatology-focused biopharmaceutical company developing novel therapies for those living with rare and severe skin diseases, today announced the appointment of Scott Braunstein …

Helo and Barrett Financial Group Sign Affiliate Agreement to Revolutionize Mortgage-Linked Financial Wellness
WESTWOOD, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- Helo Revolution (Helo), the fintech platform helping users build smarter money habits through behavioral science and automation, has signed a groundbreaking Affiliate Program Agreement with Barrett …

New Payscale Research Points to AI and Social Media Driving Salary Misinformation
1 in 5 employees are sourcing salary information from AI assistants and another 1 in 5 are turning to social media platforms like TikTok, Reddit, Instagram, and Facebook 27% of employees using AI assistants, like ChatGPT, for salary research said it gave …

Mimecast Appoints Cybersecurity Leader Patrice Perche to Board of Directors to Bolster Enterprise Growth and Global Expansion
LEXINGTON, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- Mimecast, a global cybersecurity leader redefining how organizations secure human risk through precision-engineered AI, today announced the appointment of Patrice Perche to its Board of Directors. Patrice …

Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation
CANTON, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

IPG Photonics to Announce Second Quarter 2025 Financial Results on August 5
MARLBOROUGH, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP) will release its second quarter 2025 financial results before the market opens on Tuesday, August 5, 2025. The Company will hold a conference call to review …

Coralogix Introduces MCP Server to Help Customers Build Smarter AI Agents
BOSTON, July 15, 2025 (GLOBE NEWSWIRE) -- Coralogix, a leading full-stack observability platform provider, today unveiled the official Coralogix MCP (Model Context Protocol) Server, which enables third-party AI agents to connect directly to Coralogix’s …

Scoop Up FREE Ice Cream at Stop & Shop This Weekend to Celebrate National Ice Cream Day
QUINCY, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- In celebration of National Ice Cream Day (Sunday, July 20), Stop …

Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy
BOSTON and KANSAS CITY, Kan., July 15, 2025 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, and its clinical development …

DIH Appoints Professor Nick Ward, M.D., to DIH Scientific Advisory Board
NORWELL, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH”)(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and …

Hengrui Pharma and Kailera Therapeutics Report Positive Topline Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531
– Mean weight loss of 19.2% at 6 mg with no plateau in 48-week Phase 3 trial – – Favorable safety profile consistent with other GLP-1-based treatments – – Hengrui to submit NDA in China; Kailera plans to evaluate both higher doses and longer duration of …

Addgene Announces Strategic Partnership with Promega to Launch Plasmid Collection
WATERTOWN, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed, and reproducibility, today announced a strategic partnership with Promega to expand Addgene’s vast …

Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery™ Therapy for Alzheimer’s Disease
Acumen and JCR aim to develop a product leveraging Acumen’s amyloid beta oligomer-selective antibody expertise and JCR’s transferrin-receptor-targeting blood-brain barrier-penetrating technology Preclinical candidate data expected in early 2026, with …

AAVantgarde Receives FDA Clearance to Progress Stargardt Disease Asset, AAVB-039, into CELESTE, a Phase 1/2 Clinical Trial
AAVB-039 delivers the full-length ABCA4 -protein, addressing the root cause of the disease and enabling treatment of all patients, independent of mutation CELESTE is informed by the STELLA prospective natural history study, which is currently enrolling …

Apellis Announces Five Abstracts Accepted for Oral Presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting
WALTHAM, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that five abstracts were accepted for oral presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting to be held …